keyword
https://read.qxmd.com/read/37695382/shedding-light-on-the-management-of-acute-radiation-dermatitis-insight-from-the-mascc-oncodermatology-study-group
#21
JOURNAL ARTICLE
Pierluigi Bonomo, Julie Ryan Wolf
This paper highlights a collection of eleven recently published manuscripts on the prevention and management of acute radiation dermatitis. These meta-analyses provide additional evidence for the updated clinical practice guidelines by the Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology study group for prevention and management of acute radiation dermatitis. The collection of papers elucidate the currently available evidence on acute radiation dermatitis, highlighting consolidated knowledge, effective treatments, and proposed areas for future clinical trials...
September 11, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37659054/late-breaking-abstracts-for-mascc-jascc-isoo-annual-meeting-2023
#22
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 2, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37633766/patterns-of-recurrence-in-patients-undergoing-curative-treatment-for-maxillary-alveolus-squamous-cell-carcinoma
#23
JOURNAL ARTICLE
Saadia Farooq, Farhan Zubair, Jeremy McMahon
The aim of this paper was to examine patterns of recurrence in patients undergoing curative treatment for maxillary alveolus squamous cell carcinoma (MASCC). Clinicopathological data on 41 patients undergoing curative resection for MASCC between February 2006 and May 2020 were retrospectively gathered. Outcomes included local, regional, or distant failure as first site of treatment recurrence. Univariate analysis identified significant clinicopathological variables for type of recurrence. Multivariate regression analysis generated predictive models...
October 2023: British Journal of Oral & Maxillofacial Surgery
https://read.qxmd.com/read/37568675/supportive-care-the-keystone-of-modern-oncology-practice
#24
JOURNAL ARTICLE
Florian Scotté, Amy Taylor, Andrew Davies
The Multinational Association of Supportive Care in Cancer (MASCC) defines supportive care as "the prevention and management of the adverse effects of cancer and its treatment. This includes management of physical and psychological symptoms and side effects across the continuum of the cancer journey from diagnosis through treatment to post-treatment care. Supportive care aims to improve the quality of rehabilitation, secondary cancer prevention, survivorship, and end-of-life care". This article will provide an overview of modern supportive care in cancer, discussing its definition, its relationship with palliative care, models of care, "core" service elements (multi-professional/multidisciplinary involvement), the evidence that supportive care improves morbidity, quality of life, and mortality in various groups of patients with cancer, and the health economic benefits of supportive care...
July 29, 2023: Cancers
https://read.qxmd.com/read/37563932/assessment-of-the-change-of-antiemetic-prophylaxis-from-double-to-triple-combination-in-patients-with-high-dose-carboplatin-chemotherapy
#25
JOURNAL ARTICLE
Marta Albanell-Fernández, Ángela Pérez Sánchez, Inés Monge-Escartín, Gisela Riu-Viladoms, Mª Carmen Rodríguez Mues, Mª Lourdes Corominas Bosch, Lydia Gaba García, Neus Basté Rollán, Noemí Reguart, Dolors Soy Muner, Esther Carcelero San Martín
INTRODUCTION: Chemotherapy-induced nausea and vomiting (CINV) is one of the adverse events that most affects oncologic patients' quality of life. Carboplatin AUC ≥ 4 belongs to agents with high emetic risk (moderate risk in ASCO guidelines). We aimed to compare the effectiveness of netupitant/palonosetron and dexamethasone triple combination (TC) therapy versus ondansetron and dexamethasone double combination (DC) therapy as antiemetic prophylaxis in patients with carboplatin AUC ≥ 4...
August 10, 2023: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/37500396/-translated-article-have-changes-concerning-carboplatin-and-anthracyclines-been-incorporated
#26
JOURNAL ARTICLE
Susana Redondo Capafons, Laura Soriano Gutierrez, Elsa Dalmau Portulas, Àlex Barragán Muñoz, Sergio Martínez Robles, Mònica Gómez-Valent
OBJECTIVE: Latest MASCC/ESMO guidelines of the recommendations for the prophylaxis of acute and delayed emesis induced by moderately emetogenic chemotherapy was published in 2016 incorporating anthracycline schemes as highly emetogenic chemotherapy (HEC), proposing triple antiemetic therapy to control nausea and vomiting. Likewise, they recommend triple therapy for carboplatin. The objectives of this study were to analyze the degree of concordance between guidelines and antiemetic prophylaxis used in the Chemotherapy Outpatient Unit in patients undergoing treatment with HEC and carboplatin, to evaluate its effectiveness and to determine the savings due to the use of netupitant/palonosetron (NEPA) oral (or) with intravenous (iv) dexamethasone (NEPAd) compared to iv Fosaprepitant with ondansetron and dexamethasone (FOD iv)...
July 25, 2023: Farmacia Hospitalaria
https://read.qxmd.com/read/37479822/clinical-use-of-photobiomodulation-for-the-prevention-and-treatment-of-oral-mucositis-the-real-life-experience-of-mascc-isoo-members
#27
JOURNAL ARTICLE
Ragda Abdalla-Aslan, Yehuda Zadik, Orna Intrator, Elena Bardellini, Karis Kin Fong Cheng, Paolo Bossi, Noam Yarom, Sharon Elad
AIM: To assess clinical use and patient outcome of photobiomodulation (PBM) for oral mucositis (OM) prevention and treatment among specialized practitioners. METHODS: A poll was emailed to the members of the Mucositis Study Group of MASCC/ISOO. The PBM parameters used by the respondents were analyzed using exploratory statistical methods to identify combinations of PBM parameters (patterns) that characterize the variance in the protocols (principal component analysis)...
July 21, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37468962/application-of-comprehensive-unit-based-safety-program-model-to-improve-chemotherapy-induced-nausea-and-vomiting-in-patients-with-ovarian-cancer-a-retrospective-study
#28
JOURNAL ARTICLE
Aihua Liu, Min Li, Zhuo Liu, Xinxin Xie, Wen Yao, Jingmin Wang, Tingting Zhao, Jie Yang
BACKGROUND: To explore the effect of intervention programs constructed under the guidance of the comprehensive unit-based safety program (CUSP) model on chemotherapy-induced nausea and vomiting (CINV) in patients with ovarian cancer. METHOD: According to the time of admission, 90 ovarian cancer chemotherapy patients in the first affiliated Hospital of Anhui Medical University from June 2019 to September 2020 were divided into an intervention group and a control group with 45 cases each...
July 20, 2023: Journal of Ovarian Research
https://read.qxmd.com/read/37428240/correction-to-abstracts-for-mascc-jascc-isoo-annual-meeting-2023
#29
Jocelyn White
No abstract text is available yet for this article.
July 10, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37421511/the-effect-of-hematopoietic-stem-cell-transplantation-on-patient-reported-subjective-oral-dryness-a-systematic-review-focusing-on-prevalence-severity-and-distress
#30
REVIEW
Marjolein S Bulthuis, Lucky L A van Gennip, Ewald M Bronkhorst, Nicole M A Blijlevens, Marie-Charlotte D N J M Huysmans, Stephanie J M van Leeuwen, Renske Z Thomas
OBJECTIVE: The aim of the present systematic review is to assess the prevalence and severity of and distress caused by xerostomia over time in adult hematopoietic stem cell transplantation (HSCT) recipients. METHODS: PubMed, Embase, and the Cochrane Library were searched for papers published between January 2000 and May 2022. Clinical studies were included if patient-reported subjective oral dryness was reported in adult autologous or allogeneic HSCT recipients...
July 8, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37399007/application-of-ebmt-mascc-and-qsofa-scores-to-predict-complicated-febrile-neutropenia-and-mortality-in-autologous-stem-cell-transplant-recipients
#31
JOURNAL ARTICLE
Tiago A Barros, Rony Schaffel, Geraldo S de Azevedo Neto, Bianca de Lucena Gaio, Arthur T Batista, Marcia R Valentim, Angelo Maiolino, Marcia Garnica
BACKGROUND AND OBJECTIVES: Three different scores were addressed as predictors of outcomes in autologous stem cell transplant (Auto SCT): one was calculated by pretransplant characteristics (European Society for Blood and Marrow Transplantation [EBMT] risk score), and two were calculated at the onset of febrile neutropenia (Multinational Association for Supportive Care in Cancer [MASCC] and Quick Sequential Organ Failure Assessment [qSOFA]). We considered bloodstream infection (BSI), carbapenem prescription, admission to the intensive care unit (ICU), and mortality as outcomes...
May 23, 2023: Hematology/oncology and Stem Cell Therapy
https://read.qxmd.com/read/37341793/abstracts-for-mascc-jascc-isoo-annual-meeting-2023
#32
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
June 17, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37268481/antiemetic-guidelines-have-we-incorporated-the-changes-concerning-carboplatin-and-anthracyclines
#33
JOURNAL ARTICLE
Susana Redondo Capafons, Laura Soriano Gutierrez, Elsa Dalmau Portulas, Àlex Barragán Muñoz, Sergio Martínez Robles, Mònica Gómez-Valent
OBJECTIVE: Latest MASCC/ESMO guidelines of the recommendations for the prophylaxis of acute and delayed emesis induced by moderately emetogenic chemotherapy was published in 2016 incorporating anthracycline schemes as highly emetogenic chemotherapy (HEC), proposing triple antiemetic therapy to control nausea and vomiting. Likewise, they recommend triple therapy for carboplatin. The objectives of this study were to analyze the degree of concordance between guidelines and antiemetic prophylaxis used in the Chemotherapy Outpatient Unit in patients undergoing treatment with HEC and carboplatin, to evaluate its effectiveness and to determine the savings due to the use of netupitant/palonosetron (NEPA) oral (or) with intravenous (iv) dexamethasone (NEPAd) compared to iv Fosaprepitant with ondansetron and dexamethasone (FOD iv)...
May 31, 2023: Farmacia Hospitalaria
https://read.qxmd.com/read/37222203/how-to-become-a-multinational-association-of-supportive-care-in-cancer-designated-center-of-excellence-in-supportive-care-in-cancer
#34
REVIEW
Andrea Antonuzzo, Maurizio Lucchesi, Carla Ida Ripamonti
PURPOSE OF REVIEW: Aim of this review is to encourage and involve more doctors to take care of supportive care in cancer patients and to become centers of excellence. RECENT FINDINGS: In 2019, MASCC initiated a certification program to recognize oncology centers that demonstrate best practices in supportive cancer care but literature on how to become MASCC-designated center of Excellence in Supportive Care in Cancer is scarce and will be bulleted. SUMMARY: Becoming centers of excellence means not only the recognition of the clinical and managerial requirements to provide good supportive care but also the creation of a network of centers to participate in multicenter scientific projects and thus improve knowledge in the field of supportive care in cancer patients...
July 1, 2023: Current Opinion in Oncology
https://read.qxmd.com/read/37181415/mascc-clinical-practice-guidelines-for-the-prevention-and-management-of-acute-radiation-dermatitis-part-1-systematic-review
#35
REVIEW
Tara Behroozian, Daniel Goldshtein, Julie Ryan Wolf, Corina van den Hurk, Samuel Finkelstein, Henry Lam, Partha Patel, Lauren Kanee, Shing Fung Lee, Adrian Wai Chan, Henry Chun Yip Wong, Saverio Caini, Simran Mahal, Samantha Kennedy, Edward Chow, Pierluigi Bonomo
Acute radiation dermatitis (ARD) commonly develops in cancer patients undergoing radiotherapy and is often characterized by erythema, desquamation, and pain. A systematic review was conducted to summarize the current evidence on interventions for the prevention and management of ARD. Databases were searched from 1946 to September 2020 to identify all original studies that evaluated an intervention for the prevention or management of ARD, with an updated search conducted in January 2023. A total of 235 original studies were included in this review, including 149 randomized controlled trials (RCTs)...
April 2023: EClinicalMedicine
https://read.qxmd.com/read/37148393/correction-to-mascc-guideline-cannabis-for-cancer%C3%A2-related-pain-and-risk-of-harms-and-adverse-events
#36
Josephine To, Mellar Davis, Andrea Sbrana, Bryony Alderman, David Hui, Sandip Mukhopadhyay, Carole Bouleuc, Amy A Case, Koji Amano, Gregory B Crawford, Giulia de Feo, Kimberson Tanco, Jessica Garsed
No abstract text is available yet for this article.
May 6, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37052753/systematic-review-and-meta-analysis-on-interventions-for-radiation-dermatitis-prevention-and-management-an-overview-of-the-methods
#37
REVIEW
Tara Behroozian, Saverio Caini, Corina van den Hurk, Pierluigi Bonomo, Edward Chow, Julie Ryan Wolf
Over several decades, research on the prevention and management of acute radiation dermatitis (RD) has continued to emerge, yet there remains no "gold standard" treatment for RD care. Recent guidelines on RD prevention and management were published in 2022 by the Oncodermatology Study Group of the Multinational Association of Supportive Care in Cancer (MASCC). As part of this guideline process, a collaborative effort was undertaken by international RD experts to quantitatively compare commonly studied RD skin interventions through meta-analyses and discern superiority of interventional treatments over another intervention, standard-of-care, or placebo in RD prevention and management...
April 13, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/36990615/multinational-association-of-supportive-care-in-cancer-mascc-clinical-practice-guidelines-for-the-prevention-and-management-of-acute-radiation-dermatitis-international-delphi-consensus-based-recommendations
#38
REVIEW
Tara Behroozian, Pierluigi Bonomo, Partha Patel, Lauren Kanee, Samuel Finkelstein, Corina van den Hurk, Edward Chow, Julie Ryan Wolf
Acute radiation dermatitis is a frequent adverse effect of radiotherapy, but standardisation of care for acute radiation dermatitis is lacking. Due to the conflicting evidence and variability in current guidelines, a four-round Delphi consensus process was used to compile opinions of 42 international experts on care for people with acute radiation dermatitis on the basis of the evidence in existing medical literature. Interventions for acute radiation dermatitis prevention or management that reached at least 75% consensus were recommended for clinical use...
April 2023: Lancet Oncology
https://read.qxmd.com/read/36872397/mascc-guideline-cannabis-for-cancer-related-pain-and-risk-of-harms-and-adverse-events
#39
REVIEW
Josephine To, Mellar Davis, Andrea Sbrana, Bryony Alderman, David Hui, Sandip Mukhopadhyay, Carole Bouleuc, Amy A Case, Koji Amano, Gregory B Crawford, Giulia de Feo, Kimberson Tanco, Jessica Garsed
BACKGROUND: Approximately 18% of patients with cancer use cannabis at one time as palliation or treatment for their cancer. We performed a systematic review of randomized cannabis cancer trials to establish a guideline for its use in pain and to summarize the risk of harm and adverse events when used for any indication in cancer patients. METHODS: A systematic review of randomized trials with or without meta-analysis was carried out from MEDLINE, CCTR, Embase, and PsychINFO...
March 6, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/36821961/clinical-factors-predicting-return-emergency-department-visits-in-chemotherapy-induced-febrile-neutropenia-patients
#40
JOURNAL ARTICLE
Sejin Heo, Kyeongman Jeon, Boram Park, Ryoung-Eun Ko, Taerim Kim, Sung Yeon Hwang, Hee Yoon, Tae Gun Shin, Won Chul Cha, Se Uk Lee
BACKGROUND: Although chemotherapy-induced febrile neutropenia (FN) is the most common and life-threatening oncologic emergency, the characteristics and outcomes associated with return visits to the emergency department (ED) in these patients are uncertain. Hence, we aimed to investigate the predictive factors and clinical outcomes of chemotherapy-induced FN patients returning to the ED. METHOD: This single-center, retrospective observational study spanning 14 years included chemotherapy-induced FN patients who visited the ED and were discharged...
May 2023: American Journal of Emergency Medicine
keyword
keyword
17976
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.